Next Generation Healthcare Technologies To Be Led By 2D Materials

Printer-friendly versionSend by emailPDF version

The University of Manchester recently received a grant of 5 million British Pounds for their research related to nanomaterials along with graphene in human bodies. The grant has been bestowed upon this esteemed institute for four major researches, thus, the grand total reaches somewhere near 17.7 million British Pounds. The amount is to be used in development of technologies that will address the major health issues faced by rapidly aging population of this country. 

Professor Kostas Kostarelos says, “We are delighted both with the decision by the Engineering and Physical Sciences Research Council to fund our ambitious research programme and the pharmaceutical industry support that has enthusiastically embraced 2D material technologies as particularly promising.”

This project will include engineering and design experiments on graphene that will be used to solve the unresolved issues related to healthcare. It will include specific areas like diabetes or wound cares or management of other fatal diseases that are consuming health of common people on a major basis. Neural rehabilitation through electrical stimulation for some special cases of dementia or cell therapeutics for cardiovascular and ophthalmological diseases, and other immunotherapeutics cases related to cancer will be treated under the research done under these projects. 

Distinct benefit zones using graphene and some other 2D materials will include targeted delivery of drugs that will attack the cancer cells that will leave other cells without any damage. It also aims electrical stimulation of nerves from a remote point that are under effect of neurodegenerative disorders and other problems including diabetes. There are a few other research programs that will be led by Imperial College London, University of Glasgow, and University of Leeds.